Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Regulatory News
WHO Posts New Procedure for Using Unapproved Drugs in Health Cris... 2/12/2020
NMPA Announces Implementation of Four Series Q ICH Guidelines in ... 1/21/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/20/2020
Review of Chinese Drug Registration Applications and Approvals in... 1/15/2020
NMPA Issues Notice on Matters Relating to API Registration Dossie... 1/13/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/10/2020
NMPA Publicizes List of Reference Formulations for Generic Drug E... 1/10/2020
NMPA Deputy Commissioner Meets with PMDA Chief Executive 1/10/2020
CDE Seeks Comments on Guidelines for Generic Drug Research of Pac... 1/8/2020
NMPA Publishes the List of Reference Formulations for Generic Dru... 1/8/2020
NMPA Issues Interim Guidelines for Use of Real-World Data to Supp... 1/7/2020
NMPA Issues the List of Reference Formulations for Generic Drug E... 1/7/2020
NMPA Announces Initiation of Drug Business Application System 12/31/2019
NMPA Issues Guiding Principles for Classification Standards for A... 12/31/2019
NMPA Issues the Principles and Procedures for Drug Sampling 12/30/2019
NMPA Initiates Drug Import & Export Permit Management System 12/27/2019
China Lists Lemazolam for Regulation as Class 2 Psychotropic 12/26/2019
CDE Solicits Comments on Guidelines for Clinical Protocol of Bios... 12/25/2019
NMPA Issues the Technical Guidelines for Clinical Comparability S... 12/23/2019
NMPA/CDE Commits to CDISC Standards 12/17/2019
NMPA: China Has Over 1 Mln Registered Pharmacists 12/17/2019
NMPA and NHC Issues Joint Notice for Vaccine IT Tracing Infrastru... 12/13/2019
Preview of 16 Heavy-weight New Drug Expected to be Approved in Ch... 12/13/2019
ChP Commission Solicits Comments on the draft of “Naming Princip... 12/12/2019
NMPA Issues the Guidelines for Aluminum Adjuvant in Preventative ... 12/12/2019
SAMR Solicits Public Comments on the Provisions for Registration ... 12/10/2019
NHSA issues New Policy for Drug Price Regulation 12/6/2019
NMPA Announces Withdrawal of Additional 68 Certificate Requiremen... 12/2/2019
NMPA and NHC Jointly Issues the Provisions for Drug Clinical Tria... 12/2/2019
NMPA Issues Notice on Relevant Matters for Implementation of the ... 12/2/2019
Page:1/7    Total number of articles:183  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links